EP1439777A1 - Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie - Google Patents

Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie

Info

Publication number
EP1439777A1
EP1439777A1 EP02767037A EP02767037A EP1439777A1 EP 1439777 A1 EP1439777 A1 EP 1439777A1 EP 02767037 A EP02767037 A EP 02767037A EP 02767037 A EP02767037 A EP 02767037A EP 1439777 A1 EP1439777 A1 EP 1439777A1
Authority
EP
European Patent Office
Prior art keywords
simulation device
evaluation
blood glucose
display
simulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02767037A
Other languages
German (de)
English (en)
Inventor
Thomas Vering
Heiner Kaufmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
Disetronic Licensing AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disetronic Licensing AG filed Critical Disetronic Licensing AG
Publication of EP1439777A1 publication Critical patent/EP1439777A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Definitions

  • the invention relates to simulation devices for the playful evaluation and display of blood glucose values.
  • Diabetics are required to check their blood glucose levels several times a day. This is done by taking blood independently, which is applied to a glucose measuring strip, the measuring strip is connected to the measuring and display device and the result of the measurement is finally displayed.
  • a disadvantage of the known systems is the low interactivity, as well as insufficient visual, haptic and acoustic representation of the individual measurement results or the evaluation of the measurement results achieved.
  • the object of the invention is to convey the information of the individual measurement results and the evaluation of several measurement results in succession to the patient in a visually, haptically and acoustically appealing, rather playful manner.
  • the invention solves the problem with a simulation device with a virtual creature, which communicates the evaluation with the user in different ways and with the user through signs, speech or other acoustic signals, vibration, change in temperature, size, shape or color , as well as changing the behavior of the virtual creature interacts.
  • the simulation device has a housing and a display device, e.g. in the form of a graphic LCD display. Over a
  • the user gives his input device, which is attached directly to the housing or can also be attached to a separate device Blood glucose values in a storage, evaluation and control unit, for example a microchip, for the purpose of storing the values. Of course, these can also be separate units.
  • the entered values are analyzed and assessed by the chip using a stored evaluation method.
  • the device now communicates the result of the evaluation and the measured result to the user in a playful manner.
  • the evaluation is preferably displayed with the aid of a virtual creature 6, which conveys the evaluation by means of characters, speech or other acoustic signals, change in size, shape or color, or change in the attitude or change in its behavior.
  • the evaluation of the measured values takes place in the form of heating or cooling of the entire device or only a part thereof.
  • the cooling or heating takes place by means of a common cooling or heating element.
  • the device In order to be able to operate the device also at night, it preferably has a light-emitting diode.
  • the device according to the invention can also be integrated into a PC, a mobile pocket PC or a mobile phone.
  • the measured values are transmitted directly from a blood glucose meter to the simulation device.
  • the advantage of this solution is that here no measured values have to be read from the measuring system and then entered into the simulation device via a keyboard.
  • the transfer of the Data from the measuring system to the simulation device is also carried out here either via wire or wirelessly.
  • the simulation device is integrated in a common blood glucose measurement system.
  • the device according to the invention has a special shape and / or choice of material for the housing; For example, if the device is integrated into a teddy bear, this could increase the acceptance of the simulation device in children.
  • All simulation devices can also be controlled so that not only individual blood glucose value entries change the display parameters, but by storing several values, the longer-term health situation is displayed, e.g. the more flexed the virtual creature is displayed, the worse the average of the measurements of the last month.
  • Inadequate user discipline can also be represented very well, e.g. The more the virtual creature turns reddish, the more undisciplined blood glucose values are transmitted to the simulation device.
  • the simulation device can also be referred to as a monitoring device.
  • the behavior of the virtual creature can also be changed by setting parameters. For example, the number of interactions per day of the virtual being with the diabetic could be determined.
  • 1 shows a schematic illustration of the simulation device according to the invention
  • 2a shows a schematic illustration of the simulation device according to the invention with an external input keyboard
  • FIG. 2b shows a schematic representation of the simulation device according to the invention and external blood glucose measurement system
  • FIG 3 shows a schematic representation of the simulation device according to the invention integrated in a blood glucose measurement system.
  • the simulation device has a housing 1, a display device 2, e.g. in the form of a graphic LCD display, and an "on / off" or “reset” button 3 on.
  • a display device e.g. in the form of a graphic LCD display
  • an "on / off" or “reset” button 3 on.
  • the keyboard 4 which can be attached directly to the housing, the user enters his blood glucose values into a storage, evaluation and control unit 5, e.g. a microchip for the purpose of storing the values.
  • the entered values are now analyzed and assessed by chip 5 using a stored evaluation method.
  • the device communicates the result of the evaluation and the measured result to the user.
  • the evaluation is preferably displayed using a virtual creature 6.
  • Acoustic signals are generated by means of signal generators 8. It is also possible to display the evaluation by means of a heating / cooling element (not shown). A display by a vibration element (not shown) is also possible.
  • the device In order to be able to operate the device also at night, it preferably has a light-emitting diode 7.
  • 2a shows a further embodiment of the device according to the invention.
  • the input keyboard is connected to the evaluation and display device via wireless communication or by means of wires.
  • 2b shows a further embodiment of the device according to the invention, in which the measured values, wirelessly or by means of wires, are transmitted from a blood glucose meter 9 with the measuring strip 10 shown to the simulation device.
  • FIG. 3 shows a further embodiment in which the simulation device is integrated in a common blood glucose measurement system.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

L'invention concerne un dispositif de simulation destiné à l'évaluation et à l'affichage de la glycémie (1), l'affichage de cette évaluation étant effectué au moyen d'une créature virtuelle (6).
EP02767037A 2001-10-26 2002-10-21 Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie Withdrawn EP1439777A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH197401 2001-10-26
CH19742001 2001-10-26
PCT/CH2002/000573 WO2003034912A1 (fr) 2001-10-26 2002-10-21 Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie

Publications (1)

Publication Number Publication Date
EP1439777A1 true EP1439777A1 (fr) 2004-07-28

Family

ID=4566975

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02767037A Withdrawn EP1439777A1 (fr) 2001-10-26 2002-10-21 Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie

Country Status (3)

Country Link
US (1) US20050004437A1 (fr)
EP (1) EP1439777A1 (fr)
WO (1) WO2003034912A1 (fr)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
DE10057832C1 (de) * 2000-11-21 2002-02-21 Hartmann Paul Ag Blutanalysegerät
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
WO2002100460A2 (fr) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Actionneur electrique de lancette
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
ATE450209T1 (de) * 2001-06-12 2009-12-15 Pelikan Technologies Inc Gerät und verfahren zur entnahme von blutproben
ES2357887T3 (es) * 2001-06-12 2011-05-03 Pelikan Technologies Inc. Aparato para mejorar la tasa de éxito de obtención de sangre a partir de una punción capilar.
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
AU2002348683A1 (en) * 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US20070100255A1 (en) * 2002-04-19 2007-05-03 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7547287B2 (en) * 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7976476B2 (en) * 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7481776B2 (en) * 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7485128B2 (en) * 2002-04-19 2009-02-03 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) * 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7909778B2 (en) * 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) * 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) * 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7141058B2 (en) * 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7524293B2 (en) * 2002-04-19 2009-04-28 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7232451B2 (en) * 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) * 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7297122B2 (en) * 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7563232B2 (en) * 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US20040067481A1 (en) * 2002-06-12 2004-04-08 Leslie Leonard Thermal sensor for fluid detection
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
AU2003300154A1 (en) * 2002-12-31 2004-07-29 Pelikan Technologies Inc. Method and apparatus for loading penetrating members
DK1633235T3 (da) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparat til udtagelse af legemsvæskeprøver og detektering af analyt
US20060241666A1 (en) * 2003-06-11 2006-10-26 Briggs Barry D Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (fr) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Element penetrant peu douloureux
EP1671096A4 (fr) 2003-09-29 2009-09-16 Pelikan Technologies Inc Procede et appareil permettant d'obtenir un dispositif de capture d'echantillons ameliore
US9351680B2 (en) * 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
EP1706026B1 (fr) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Procédé et appareil permettant d'améliorer le flux fluidique et le prélèvement d'échantillons
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1751546A2 (fr) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Hydrogel imprimable pour biocapteurs
WO2005120365A1 (fr) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Procede et appareil pour la fabrication d'un dispositif d'echantillonnage de liquides
AT7892U3 (de) * 2004-12-21 2006-08-15 Evelyne Lorenz Elektronisches diabetikertagebuch
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20070276290A1 (en) * 2005-10-04 2007-11-29 Dirk Boecker Tissue Penetrating Apparatus
WO2007044599A2 (fr) * 2005-10-06 2007-04-19 Hamilton Scott E Systeme de controle de donnees connecte a un ipodmc
FR2913191A1 (fr) * 2007-03-02 2008-09-05 Eric Szatkowski Dispositif permettant d'interpreter facilement et rapidement l'affichage numerique du taux de sucre issu d'un lecteur de glycemie.
EP2265324B1 (fr) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Système intégré de mesure d'analytes
ATE507769T1 (de) 2008-10-16 2011-05-15 Hoffmann La Roche Kinderfreundliches blutglucosemessgerät
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2014115851A1 (fr) * 2013-01-25 2014-07-31 テルモ株式会社 Glucomètre sanguin
US10963774B2 (en) 2017-01-09 2021-03-30 Microsoft Technology Licensing, Llc Systems and methods for artificial intelligence interface generation, evolution, and/or adjustment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5918603A (en) * 1994-05-23 1999-07-06 Health Hero Network, Inc. Method for treating medical conditions using a microprocessor-based video game
US6186145B1 (en) * 1994-05-23 2001-02-13 Health Hero Network, Inc. Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator
US5913310A (en) * 1994-05-23 1999-06-22 Health Hero Network, Inc. Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game
US5678571A (en) * 1994-05-23 1997-10-21 Raya Systems, Inc. Method for treating medical conditions using a microprocessor-based video game
US6032119A (en) * 1997-01-16 2000-02-29 Health Hero Network, Inc. Personalized display of health information
US6558320B1 (en) * 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6188648B1 (en) * 1998-11-03 2001-02-13 Toni L. Olsen Diabetic care overview wristwatch
US6639614B1 (en) * 2000-07-10 2003-10-28 Stephen Michael Kosslyn Multi-variate data presentation method using ecologically valid stimuli
AU2002336598A1 (en) * 2001-09-19 2003-04-01 Ambient Devices Inc. System and method for presentation of remote information in ambient form
US20050101841A9 (en) * 2001-12-04 2005-05-12 Kimberly-Clark Worldwide, Inc. Healthcare networks with biosensors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03034912A1 *

Also Published As

Publication number Publication date
WO2003034912A1 (fr) 2003-05-01
US20050004437A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
EP1439777A1 (fr) Dispositif de simulation destine a l'evaluation et a l'affichage ludiques de la glycemie
DE60210342T2 (de) Mit einer graphischen repräsentationsanzeige ausgestattete vorrichtung zur messung eines biologischen parameters
DE112012005712T5 (de) Schlafanzeigeprogramm, Schlafanzeigeverfahren und Schlafanzeigevorrichtung
EP1733677A1 (fr) Dispositif de mesure de glucose avec moyen de signalisation
DE102015001395A1 (de) Vorrichtung, Verfahren und Programm zur Auswertung von Körperveränderungen
DE19747879A1 (de) Vorrichtung zur Zeiterfassung
EP3203331B1 (fr) Transmission proactive de valeurs de mesure à des terminaux mobiles
DE202012102486U1 (de) Messvorrichtung
DE60108976T2 (de) Vorrichtung zur unterstützung von aktivitäten
WO2019001971A1 (fr) Procédé et système de détermination d'une recommandation en matière d'hygiène bucco-dentaire
DE112010000038B4 (de) Eine multifunktionale elektronische Waage mit Unterhaltungswert
DE202004000813U1 (de) Elektronisches Ohrthermometer für mehrere Messungen und mit Speicherfunktion
WO2007124608A2 (fr) Dispositif et procédé pour la détection, l'affichage et l'évaluation de données électroniques mobiles
DE112012004514T5 (de) Anpassen der Benutzererfahrung in steuerbaren Ereignissen
DE60117329T2 (de) Gerät zur Verwaltung des weiblichen physischen Zustands
EP2181323B1 (fr) Appareil de champ pour l'automatisation des processus
DE10001296A1 (de) Vorrichtung zur Eingabe, Berechnung und Darstellung eines Spielstandes eines Tennisspieles
EP2377460A1 (fr) Système de reconnaissance précoce d'états mettant la vie de personnes en danger
DE10163564A1 (de) Feldgerät
DE212016000069U1 (de) Vorrichtung zum automatischen Messen eines Zustandes eines Benutzers
DE112016001444B4 (de) Trainingsinformations-Messvorrichtung, Trainingsmanagementverfahren und Trainingsmanagementprogramm
EP1091286A3 (fr) Dispositif d'affichage d'informations
DE202006007261U1 (de) Kontrolleinrichtung für Glukosewerte
DE112020004960T9 (de) Elektrokardiografische messvorrichtung
DE202016107229U1 (de) Verbessertes Stirn- und Ohrenthermometer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DISETRONIC LICENSING AG

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ROCHE DIAGNOSTICS GMBH

Owner name: F. HOFFMANN-LA ROCHE AG

17Q First examination report despatched

Effective date: 20091029

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100511